Publications
Detailed Information
류마티스 관절염의 약물치료(II): 사용중인 생물학적 제제 및 개발중인 약제 : Medical treatment of rheumatoid arthritis (II): current biologic agents and newly developing drugs
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 송영욱 | - |
dc.contributor.author | 김진현 | - |
dc.date.accessioned | 2012-06-27T08:59:39Z | - |
dc.date.available | 2012-06-27T08:59:39Z | - |
dc.date.issued | 2010-10 | - |
dc.identifier.citation | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION; Vol.53 10; 880-888 | ko_KR |
dc.identifier.issn | 1975-8456 | - |
dc.identifier.uri | https://hdl.handle.net/10371/77661 | - |
dc.description.abstract | Disease-modifying antirheumatic drugs (DMARD) have been used to treat rheumatoid arthritis (RA). However, they have limited efficacy and a considerable adverse event profile. Excess production of soluble cytokines, including tumor necrosis factor (TNF), interleukin-1 (IL-1), and IL-6, appears to mediate the chronic inflammation associated with RA. Clinical trials with targeted anticytokine biologic agents, including anti-TNF alpha antibodies (adalimumab, infliximab, golimumab, cedolizumab), anti-IL-6 receptor antibodies (tocilizumab), and the soluble tumor necrosis factor-a receptor (etanercept), have shown remarkable efficacy in the treatment of RA. In addition, costimulatory blockade (abatacept) and B cell depletion (rituximab) have been employed as important adjunctive therapies in RA. Judicious use of these agents, considering their benefits and risks, would bring the greatest benefit to RA patients. The optimal conditions for the administration and indication of these drugs are under investigation. Signal transduction is another target of newly developing drugs. Because of the development of anti-TNF therapy and other biologics, there have been great advances in the treatment of RA. | ko_KR |
dc.description.sponsorship | This study was supported by a grant of the Korea
Healthcare technology R&D Project, Ministry for Health and Welfare, Republic of Korea (A084794). | ko_KR |
dc.language.iso | ko | ko_KR |
dc.publisher | KOREAN MEDICAL ASSOC | ko_KR |
dc.subject | Rheumatoid arthritis | ko_KR |
dc.subject | Kinase inhibitor | ko_KR |
dc.subject | Secondary signal | ko_KR |
dc.subject | Cytokine | ko_KR |
dc.subject | B cell depletion | ko_KR |
dc.title | 류마티스 관절염의 약물치료(II): 사용중인 생물학적 제제 및 개발중인 약제 | ko_KR |
dc.title.alternative | Medical treatment of rheumatoid arthritis (II): current biologic agents and newly developing drugs | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | Song, Yeong-Wook | - |
dc.contributor.AlternativeAuthor | Kim, Jinhyun | - |
dc.identifier.doi | 10.5124/jkma.2010.53.10.880 | - |
dc.citation.journaltitle | JOURNAL OF THE KOREAN MEDICAL ASSOCIATION | - |
dc.description.citedreference | Vassilopoulos D, 2010, ANN RHEUM DIS, V69, P1352, DOI 10.1136/ard.2009.127233 | - |
dc.description.citedreference | Cohen S, 2010, CURR OPIN RHEUMATOL, V22, P330, DOI 10.1097/BOR.0b013e3283378e6f | - |
dc.description.citedreference | Kim YJ, 2010, J RHEUMATOL, V37, P346, DOI 10.3899/jrheum.090436 | - |
dc.description.citedreference | Fleischmann RM, 2009, ARTHRITIS RHEUM, V60, P3225, DOI 10.1002/art.24906 | - |
dc.description.citedreference | Chung SJ, 2009, J RHEUMATOL, V36, P2416, DOI 10.3899/jrheum.081324 | - |
dc.description.citedreference | Kremer JM, 2009, ARTHRITIS RHEUM, V60, P1895, DOI 10.1002/art.24567 | - |
dc.description.citedreference | Carson KR, 2009, BLOOD, V113, P4834, DOI 10.1182/blood-2008-10-186999 | - |
dc.description.citedreference | Damjanov N, 2009, ARTHRITIS RHEUM, V60, P1232, DOI 10.1002/art.24485 | - |
dc.description.citedreference | Keystone E, 2009, ANN RHEUM DIS, V68, P216, DOI 10.1136/ard.2007.085787 | - |
dc.description.citedreference | Charpin C, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2868 | - |
dc.description.citedreference | Salliot C, 2009, ANN RHEUM DIS, V68, P25, DOI 10.1136/ard.2007.083188 | - |
dc.description.citedreference | Moreland LW, 2009, ANN NY ACAD SCI, V1182, P88, DOI 10.1111/j.1749-6632.2009.05072.x | - |
dc.description.citedreference | Maxwell L, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007277.pub2 | - |
dc.description.citedreference | KUKAR M, 2009, BIOLOGICS, V3, P443 | - |
dc.description.citedreference | Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932 | - |
dc.description.citedreference | Weinblatt ME, 2008, ARTHRITIS RHEUM, V58, P3309, DOI 10.1002/art.23992 | - |
dc.description.citedreference | Emery P, 2008, LANCET, V372, P375 | - |
dc.description.citedreference | Smolen JS, 2008, LANCET, V371, P987 | - |
dc.description.citedreference | Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404 | - |
dc.description.citedreference | Keystone E, 2007, ARTHRITIS RHEUM, V56, P3896, DOI 10.1002/art.23059 | - |
dc.description.citedreference | Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064 | - |
dc.description.citedreference | Wolfe F, 2007, ARTHRITIS RHEUM, V56, P2886, DOI 10.1002/art.22864 | - |
dc.description.citedreference | Finckh A, 2007, ARTHRITIS RHEUM, V56, P1417, DOI 10.1002/art.22520 | - |
dc.description.citedreference | SONG JS, 2007, J KOREAN RHEUM ASS, V14, P1 | - |
dc.description.citedreference | Cohen SB, 2006, ARTHRITIS RHEUM, V54, P2793, DOI 10.1002/art.22025 | - |
dc.description.citedreference | Setoguchi S, 2006, ARTHRITIS RHEUM, V54, P2757, DOI 10.1002/art.22056 | - |
dc.description.citedreference | Kremer JM, 2006, ANN INTERN MED, V144, P865 | - |
dc.description.citedreference | Bongartz T, 2006, JAMA-J AM MED ASSOC, V295, P2275 | - |
dc.description.citedreference | Breedveld FC, 2006, ARTHRITIS RHEUM, V54, P26, DOI 10.1002/art.21519 | - |
dc.description.citedreference | Genovese MC, 2005, NEW ENGL J MED, V353, P1114 | - |
dc.description.citedreference | Genovese MC, 2004, ARTHRITIS RHEUM, V50, P1412, DOI 10.1002/art.20221 | - |
dc.description.citedreference | Keystone EC, 2004, ARTHRITIS RHEUM, V50, P1400, DOI 10.1002/art.20217 | - |
dc.description.citedreference | Klareskog L, 2004, LANCET, V363, P675 | - |
dc.description.citedreference | STCLAIR EW, 2004, ARTHRITIS RHEUM, V50, P3432 | - |
dc.description.citedreference | Lipsky PE, 2000, NEW ENGL J MED, V343, P1594 | - |
dc.description.citedreference | Maini R, 1999, LANCET, V354, P1932 | - |
dc.description.citedreference | *KOR FOOD DRUG ADM, GUID TREATM LAT TUB | - |
dc.description.citedreference | STONE JH, OVERVIEW BIOL AGENTS | - |
dc.description.citedreference | *CTR BIOL EV RES, WHAT IS BIOL PROD | - |
dc.description.citedreference | CHATZIDIONYSIOU K, 2009 EULAR SCI M STO | - |
dc.description.tc | 0 | - |
- Appears in Collections:
- Files in This Item:
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.